Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Return on Assets (2021 - 2023)

Historic Return on Assets for Cullinan Therapeutics (CGEM) over the last 3 years, with Q3 2023 value amounting to 0.31%.

  • Cullinan Therapeutics' Return on Assets fell 4700.0% to 0.31% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.31%, marking a year-over-year decrease of 4700.0%. This contributed to the annual value of 0.22% for FY2022, which is 4300.0% up from last year.
  • Cullinan Therapeutics' Return on Assets amounted to 0.31% in Q3 2023, which was down 4700.0% from 0.27% recorded in Q2 2023.
  • Cullinan Therapeutics' 5-year Return on Assets high stood at 0.2% for Q2 2022, and its period low was 0.31% during Q3 2023.
  • Over the past 3 years, Cullinan Therapeutics' median Return on Assets value was 0.03% (recorded in 2021), while the average stood at 0.03%.
  • In the last 5 years, Cullinan Therapeutics' Return on Assets soared by 3400bps in 2022 and then crashed by -4700bps in 2023.
  • Cullinan Therapeutics' Return on Assets (Quarter) stood at 0.15% in 2021, then soared by 222bps to 0.19% in 2022, then crashed by -266bps to 0.31% in 2023.
  • Its Return on Assets was 0.31% in Q3 2023, compared to 0.27% in Q2 2023 and 0.12% in Q1 2023.